The Pharma Letter5h
US FDA issues more warning letters to Asian producers
The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...
US FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
Cookies Recall Update as FDA Sets Risk Level
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
Interesting Engineering on MSN2d
US FDA approves first-ever smart glasses with hearing aid for mild to moderate loss
EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...
What FDA Recalls In 2024 Taught Us About Food And Consumer Trust
From mislabeled allergens to major contamination scares, each incident was a reminder of how deeply food safety is woven into ...
US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
Tariff threats take aim at fentanyl trafficking. Here’s how the drug reaches the US
President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...
Nature7d
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
OTC hearing aid eyeglasses available soon in US following FDA approval
Nuance Audio showcased its glasses with built-in hearing aids at CES 2025. Now that the product is FDA-approved, it will be available in the US in the coming months.